US Patent

US9907751 — Composition and method of use of colchicine oral liquid

Formulation · Assigned to Rxomeg Therapeutics LLC · Expires 2036-11-22 · 11y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a composition and method of use for an oral liquid formulation of colchicine.

USPTO Abstract

Oral liquid colchicine formulations are described herein. Methods of using the oral liquid colchicine formulations are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
US9907751
Jurisdiction
US
Classification
Formulation
Expires
2036-11-22
Drug substance claim
No
Drug product claim
Yes
Assignee
Rxomeg Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.